Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: Evidence of free radical-mediated injury

Arthritis and Rheumatism

Volumn 43, Issue 4, 2000, Pages 894-900

  Solans, Roser ^a   Motta, Claude ^b   Solá, Rosa ^c   La Ville, Agnes E ^c   Lima, Joan ^a   Simeón, Pilar ^a   Montellá, Nuria ^a   Armadans Gil, Lluis ^a   Fonollosa, Vicent ^a   Vilardell, Miquel ^a  

^a LaboratorisClínics Hospital de la Valld'Hebron   (Spain)

^b HÔTEL DIEU   (France)

^c Sant Joan University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; ANTIBODY; CARBON MONOXIDE; CHOLESTEROL; DNA TOPOISOMERASE; FREE RADICAL; LIPID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; ISCHEMIA; LIPID ANALYSIS; LIPID COMPOSITION; LIPID PEROXIDATION; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION; SYSTEMIC SCLEROSIS;

ERYTHROCYTE MEMBRANE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPIDS; MEMBRANE FLUIDITY; OXIDATIVE STRESS; SCLERODERMA, SYSTEMIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0033857245     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200004)43:4<894::AID-ANR22>3.0.CO;2-4     Document Type: Article

References (47)

1. Vascular disease in scleroderma
2. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis
3. Influence of reduced red cell deformability on regional blood flow
4. Blood fluidity as a consequence of red cell fluidity: Flow properties of blood and flow behavior of blood in vascular discases
5. Role of blood cell wall interactions in thrombogenesis and atherogenesis: A microrheological study
6. Red blood cell size is important for adherence of blood platelets to artery subendothelium
7. Membrane fluidity and cellular functions
8. Abnormalities of cell-membrane fluidity in the pathogenesis of disease
9. Raynaud's phenomenon: Its relevance to scleroderma
10. A radical proposal for the pathogenesis of scleroderma
11. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma
12. Clinical epidemiology of toxic-oil syndrome: Manifestations of a new illness
13. Bleomycin-induced scleroderma
14. Clinicoepidemiological perspective of systemic sclerosis
15. Alterations in human vascular endothelial cell function by oxygen free radicals
16. Modulation of fibroblast proliferation by oxygen free radicals
17. Lipid peroxidation in human red cells
18. Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium
19. Peroxidation-induced perturbation of erythrocyte lipid organization
20. Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome
21. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
22. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
23. Widefield capillary microscopy: Technique and rating scale for abnormalities seen in scleroderma and related disorders
24. Sulrvival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis
25. Preparation of impermeable ghost and insideout vesicles from human erythrocyte membranes
26. Fluidity parameters of lipid regions determined by fluorescence polarization
27. Fluorimetry of turbid and absorbent samples and the membrane fluidity of intact erythrocytes
28. Preparation of lipid extracts from brain tissue
29. Effects of dietary fats on the fluidity of human high-density lipoprotein: Influence of the overall composition and phospholipid fatty acids
30. A rapid assay for cholesterol and choline phospholipids in erythrocyte membranes
31. Lipid peroxides and human diseases
32. Rheological and kinetic dysfunctions of the cholesterol-loaded, human erythrocytes
33. Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease
34. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function
35. Dietary intake and nutritional status in patients with systemic sclerosis
36. Free radical-mediated lipid peroxidation in cells: Oxidizability is a function of cell-lipid bisallylic hydrogen content
37. Physicochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysis-generated oxyradicals: Effect on their cholesterol effluxing capacity
38. Free radical lipid oxidation affects cholesterol transfer between lipoproteins and erythrocytes
39. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis
40. Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon
41. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome
42. Effect of essential fatty acid deficiency on forskolin binding sites, adenylate cyclase and cyclic AMP-dependent protein kinase activity, the levels of G proteins and ventricular function in rat heart
43. Effects of altered cardiac membrane fluidity on β-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy
44. Hepatocyte membrane stabilization by prostaglandins E1 and E2: Favorable effects on rat liver injury
45. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases
46. Micronutrient status in patients with primary Raynaud's phenomenon and systemic sclerosis